Shares digital

Concateno (COT:AIM) – Finals PTP: £0.3m (-£0.8m) Divi: n/a (n/a)

The medical diagnostics and drug testing company moved into pre-tax profits at finals and said it still has some targeted acquisitions in its sights. It is particularly keen to make more ground in Scandinavia, mainland Europe, Australia and New Zealand and had £2.2 million cash at the end of 2007.

Its most recent acquisition was drug testing business Cozart for £65.5 million in October, and it has already identified £3 million of savings by merging operations. Trading so far in 2008 has been in line with the company's expectations and it says that it has strong visibility with key customers for a period of between three and five years. The shares remained stable on the results but at 121.5p are well off last year’s highs of 180.5p.

Shares says: Operates in a growing industry, shares should rebound from current lows.

by: Susanna Twidale